Insider · CIK 0001202769

BERNS PAUL L

Reports to the SEC for 13 companies · WATERTOWN, MA

sec.gov

Transactions

Companies

Filings

CIK

0001202769

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-20	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, See Remarks	AAward	+500K sh	—	—	500,000
2026-06-22	KARDKardigan, Inc.P Purchase	Director, 10% Owner	PPurchase	+1.25M sh	$16.00	+$20M	15,042,035
2026-06-17	KARDKardigan, Inc. · Series B-1 Preferred StockC Conversion	Director, 10% Owner	CConversion	−2.31M sh	—	—	0
2026-06-17	KARDKardigan, Inc. · Series A Preferred StockC Conversion	Director, 10% Owner	CConversion	−5.15M sh	—	—	0
2026-06-17	KARDKardigan, Inc.C Conversion	Director, 10% Owner	CConversion	+13.8M sh	—	—	13,792,035
2026-06-17	KARDKardigan, Inc. · Series B Preferred StockC Conversion	Director, 10% Owner	CConversion	−1.2M sh	—	—	0
2026-06-17	KARDKardigan, Inc.A Award	Director, 10% Owner	AAward	+20.7K sh	—	—	20,706
2026-02-17	NMRANeumora Therapeutics, Inc.S Sale	Director, See Remarks	SSale	−9,819 sh	$3.51	−$34.5K	7,395,185
2026-01-08	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, See Remarks	AAward	+1.65M sh	—	—	1,650,000
2025-11-13	MTSRMetsera, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−24.2K sh	—	—	0
2025-11-13	MTSRMetsera, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−223K sh	—	—	0
2025-11-13	MTSRMetsera, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−8.31M sh	—	—	0
2025-11-13	MTSRMetsera, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−958K sh	—	—	0
2025-11-13	MTSRMetsera, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−7.52M sh	—	—	0
2025-11-13	MTSRMetsera, Inc. · Restricted Stock UnitA Award	Director	AAward	+4,031 sh	—	—	4,031
2025-11-13	MTSRMetsera, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−4,031 sh	—	—	0
2025-05-28	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, See Remarks	AAward	+343K sh	—	—	342,500
2025-05-28	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−956K sh	—	—	0
2025-05-28	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, See Remarks	AAward	+2M sh	—	—	2,000,000
2025-05-28	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−2M sh	—	—	0
2025-05-28	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, See Remarks	AAward	+497K sh	—	—	497,049
2025-05-28	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−343K sh	—	—	0
2025-05-28	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−497K sh	—	—	0
2025-05-28	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, See Remarks	AAward	+956K sh	—	—	955,864
2025-05-20	MTSRMetsera, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+24.2K sh	—	—	24,188
2025-02-18	NMRANeumora Therapeutics, Inc.S Sale	Director, See Remarks	SSale	−13.9K sh	$1.69	−$23.5K	7,405,004
2025-02-13	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, See Remarks	AAward	+497K sh	—	—	497,049
2025-02-13	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−956K sh	—	—	0
2025-02-13	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−343K sh	—	—	0
2025-02-13	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, See Remarks	AAward	+2M sh	—	—	2,000,000
2025-02-13	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, See Remarks	AAward	+343K sh	—	—	342,500
2025-02-13	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−497K sh	—	—	0
2025-02-13	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, See Remarks	AAward	+956K sh	—	—	955,864
2025-02-03	MTSRMetsera, Inc.C Conversion	Director	CConversion	+7.52M sh	—	—	7,523,682
2025-02-03	MTSRMetsera, Inc.P Purchase	Director	PPurchase	+790K sh	$18.00	+$14.2M	8,313,680
2025-02-03	MTSRMetsera, Inc. · Series A Convertible Preferred StockC Conversion	Director	CConversion	−15M sh	—	—	0
2025-02-03	MTSRMetsera, Inc. · Series B Convertible Preferred StockC Conversion	Director	CConversion	−2.68M sh	—	—	0
2024-12-27	NMRANeumora Therapeutics, Inc.G Gift	Director, See Remarks	GGift	−133K sh	—	—	7,418,875
2024-12-27	NMRANeumora Therapeutics, Inc.G Gift	Director, See Remarks	GGift	−133K sh	—	—	7,551,972
2024-12-27	NMRANeumora Therapeutics, Inc.G Gift	Director, See Remarks	GGift	−133K sh	—	—	7,685,069
2024-06-21	Unity Biotechnology, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2024-02-14	NMRANeumora Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, See Remarks	AAward	+343K sh	—	—	342,500
2024-02-14	NMRANeumora Therapeutics, Inc.A Award	Director, See Remarks	AAward	+171K sh	—	—	7,818,166
2023-11-09	EQRx, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−101K sh	—	—	0
2023-11-09	EQRx, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−627K sh	—	—	0
2023-11-09	EQRx, Inc.Earn-out SharesD Disposition to Issuer	Director	DDisposition to Issuer	−86.3K sh	—	—	0
2023-06-23	Unity Biotechnology, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2023-01-01	EQRx, Inc.Earn-out SharesA Award	Director	AAward	+453 sh	—	—	86,344
2022-09-30	EQRx, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+101K sh	—	—	101,010
2022-06-24	Unity Biotechnology, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000

Recent filings

Accepted (ET)
Aug 214
BERNS PAUL L0001610717-26-000384
SEC(opens sec.gov)
Jun 244
BERNS PAUL L0001012975-26-000565
SEC(opens sec.gov)
Jun 224
BERNS PAUL L0001193125-26-277936
SEC(opens sec.gov)
Feb 194
BERNS PAUL L0001610717-26-000052
SEC(opens sec.gov)
Jan 94
BERNS PAUL L0001610717-26-000008
SEC(opens sec.gov)
Nov 134
BERNS PAUL L0001193125-25-280813
SEC(opens sec.gov)
May 304
BERNS PAUL L0000950170-25-079920
SEC(opens sec.gov)

Companies

Address

C/O NEUMORA THERAPEUTICS, INC. 260 ARSENAL PLACE, SUITE 1

WATERTOWN, MA, 02472